Clinical Trials Logo

Filter by:
NCT ID: NCT03309618 Completed - Clinical trials for Myocardial Infarction

Post- Myocardial Infarction Arterial Wall Improvement by Low-dose Fluvastatin and Valsartan

Start date: November 2012
Phase: N/A
Study type: Interventional

The concept of improving arterial wall characteristics by treatment with a very low-dose combination of fluvastatin and valsartan (low-flu/val) in stable, post-myocardial infarction (MI) patients was tested. The parameters of endothelial function (flow mediated dilatation (FMD), reactive hyperemia index) and arterial stiffness (carotid-femoral pulse wave velocity (cf-PWV), local carotid PWV and β-stiffness coefficient) were measured before and after 30 days of treatment, and the residual effect was assessed 10 weeks later. So the investigators explored whether low-flu/val added "on-top-of" optimal therapy could improve endothelial function and arterial stiffness in post-MI patients. Since these improved parameters are well-known predictors of future coronary events, such treatment could decrease cardiovascular risk.

NCT ID: NCT03306394 Completed - Clinical trials for Metastatic Colorectal Cancer

A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).

PRECONNECT
Start date: October 18, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to collect additional safety and efficacy data during treatment with trifluridine / tipiracil in patients with a pretreated metastatic colorectal cancer (mCRC). Eligible patients may receive an early access to trifluridine / tipiracil through this clinical study until progression of disease, unacceptable toxicity, investigator decision, patient refusal or until market authorization or reimbursement has been granted by the relevant Authority of the country where that patient is treated or until trifluridine / tipiracil is available by a doctor's prescription or can be accessed from another source or Sponsor decision.

NCT ID: NCT03298789 Completed - Clinical trials for Only Healthy Participants Are Included in the Study

Acute Effects of Static Stretching in Warm-up

AESSW
Start date: July 22, 2017
Phase: N/A
Study type: Interventional

In this study the investigators want to address acute effects of warm-up and static stretching on short-term muscular performance of football players. Static stretching exercises are often used in the first part of a training session or before a football match in order to increase sports performance and to decrease risk of injuries. Since there is a lot of scientific evidence that demonstrates static stretching can improve short-term muscle performance, the aim of researchers is to discover the size and the duration of negative effects and, additionally, whether these effects can be eliminated with activation exercises. Nineteen 14 years old football players will be included in a cross-over study design. In the control condition the participants will perform 5 minutes of aerobic warm-up (stepping on the stair) and then 7 series of 20-seconds static stretching of quadriceps femoris, hamstrings, hip adductors and triceps surae. Maximal power and jump height of the countermovement jump will be tested in between every series. Thus, parameters of countermovement jump will be monitored at the beginning, after warm-up, after each series of static stretching, 7.5 minutes after 7th static stretching series and 15 minutes after 7th static stretching series. Parameters of dynamometry (relative maximal torque [Nm/kgBM] and rate of torque developement [Nm/s/kgBM] will be monitored at the beginning, after warm up, 7.5 minutes after last series of static stretching and 15 minutes after last series of static stretching. Maximal range of motion will be monitored at the beginning, after warm up, during every series of static stretching, after last series of static stretching, 7.5 minutes after last series of static stretching and 15 minutes after last series of static stretching. In the second condition (experimental) all the tasks are the same, the only difference is that the subjects must perform post-activation potentiation exercises after last series of static stretching. We hypothesize that muscular performance will be impaired to a statistically significant level after 7th series of static stretching. Second hypothesis is that negative effects will not last longer than 15 minutes and the last hypothesis is that static stretching induced negative effects can be nullified with activation exercises.

NCT ID: NCT03293082 Completed - Clinical trials for Type 1 Diabetes Mellitus

Preschool CGM Use and Glucose Variability in Type 1 Diabetes

Start date: September 30, 2017
Phase: N/A
Study type: Observational [Patient Registry]

The objectives of this clinical study is to evaluate the efficacy continuous glucose monitoring (CGM) use on glucose variability (GV) in preschool children with T1D treated with CSII. Downloads from CGM and CSII saved in pdf from will be retrospectively reviewed and analysed for all preschool children with type 1 diabetes in Slovenia. Glucose variability and other glycemic parameters will be analyzed separately for periods when CGM was used (CGM and SMBG data) and compared to periods when CGM was not used (SMBG only data).

NCT ID: NCT03285919 Completed - Stroke Clinical Trials

Perturbed-balance Training During Treadmill Walking for Stroke Subjects

BALANCESI
Start date: December 5, 2016
Phase: N/A
Study type: Interventional

A control and a post-stroke subject with right-side chronic hemiparesis were studied. The post-stroke subject underwent 30 sessions of balance-perturbed training while walking on an instrumented treadmill where the Balance Assessment Robot (BAR™) randomly delivered pushes to pelvis in various directions at various speeds and at various perturbation amplitudes. The investigators assessed kinematics, kinetics, electromiography and spatio-temporal responses to outward-directed perturbations commencing either at foot contact of the left or the right leg.

NCT ID: NCT03285763 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

A Study of Atezolizumab (Tecentriq) to Investigate Long-term Safety and Efficacy in Previously-treated Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

TAIL
Start date: October 25, 2017
Phase: Phase 4
Study type: Interventional

This is a Phase III/IV, single-arm, multicenter study of the long-term safety and efficacy of atezolizumab treatment in participants with Stage IIIb or Stage IV NSCLC who have progressed after standard systemic chemotherapy (including if given in combination with anti-programmed cell death protein 1 [anti-PD-1] therapy, after anti-PD-1 as monotherapy, or after tyrosine kinase inhibitor [TKI] therapy). The study will consist of a Screening Period, a Treatment Period, a Treatment Discontinuation Visit, and a Follow-Up Period.

NCT ID: NCT03284840 Completed - Clinical trials for Vitamin D Deficiency

Adults Nutrition as a Protective or Health-risk Factor

NUTRIHEALTH
Start date: June 1, 2017
Phase:
Study type: Observational

To obtain up-to-date data on nutrient intakes in adults, a national dietary survey - the EU Menu study will be conducted during 12 consecutive months in 2017/2018, providing data on the consumption of foods and enabling the assessment of energy and macronutrient intakes. Participating subjects will be invited to NUTRIHEALTH study for assessment for micronutrient status (focusing into vitamin D, folic acid, vitamin B12, and iron) and medical examination, in which thyroid size will be aslo measured, to investigated thyroid epidemiology in Slovenia.

NCT ID: NCT03284814 Completed - Clinical trials for Bioavailability of Coenzyme Q10

Bioavailability Study of CoQ10 Formulations in Healthy Elderly Adults

CoQ10-01
Start date: August 29, 2017
Phase: N/A
Study type: Interventional

The single-center, randomized, open-label, three-period crossover bioavailability study will include 21 subjects who will test three CoQ10 formulations. Subjects will test 3 formulations of single dose CoQ10 within first 3 weeks to assess bioavailability, which will be followed with 2 weeks of continuous administration of one of study formulations to demonstrate and assesse multiple-dose profile of CoQ10.

NCT ID: NCT03282968 Completed - Stroke Clinical Trials

Balance Training After Stroke With REWIRE

REWIRESI
Start date: January 3, 2017
Phase: N/A
Study type: Interventional

The study will include 20 patients after stroke, randomly assigned to the experimental and control group (10 each). In both groups, the program with last for five days; walking and balance will be assessed before and after the program. Both groups will receive regular neurophysiotherapy; in addition, the experimental group will exercise each day by playing REWIRE games, while the control group will perform standing balance exercises.

NCT ID: NCT03279380 Recruiting - Exercise Clinical Trials

Gene-Exercise Interactions in Athletes

GE-EX
Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Athlete status is a heritable trait that could be explained with a number of potentially important DNA polymorphisms contributing to predisposition to success in certain types of sport. The first aim of the study is to determine the genetic profile of Slovenian athletes. The associations of 30 common gene polymorphisms with aerobic and anaerobic athlete status will be investigated as a single and polygenic profile. The second aim is to investigate the impact of the genetic variants contributing to different acute response to low vs. high intensity exercise. Physiological and biochemical measurements will be carried out. Variability in physiological adaptation in response to exercise will provides an opportunity to study the relationship between the molecular response to exercise and the extent of physiological changes in athletes. Currently, it is not yet clear whether different genetic variant associated with exercise responses remains uniform, with different exercise intensities, structure and duration of exercise.